BioWorld MedTech

July 29, 2015

View Archived Issues

Bacterin Fuses with X-Spine: Management cites cross-selling opp as backbone of $86M cash-stock deal

A significant cross-selling opportunity and a broader product offering are being cited as the strategic backbone of a $86 million cash-and-stock deal that will combine two device companies operating in the spine market. Read More

Greater China Conference: China's health care push presents a host of opportunities for Taiwan market

Read More

Inside the Beltway: FDA to evaluate gadolinium in response to reports in literature

Read More

AACC Conference: Roche still 'likes' diabetes business; has no plans to sell troubled unit

Read More

Financings: Deerfield launches $550M health care venture cap fund

Read More

Court Report: Nuvasive reports reaching definitive settlement with DOJ

Read More

World in Review: Guided Therapeutics says Turkish distributor awarded contract by MOH

Read More

Agreements/contracts: ViiMed using InterSystems to integrate EHR technology

Read More

Hit Bits: DMHI releases new version of Virtual Physician's Network

Read More

People in Places

Read More

Briefly noted

Read More

Products

Read More

MDD's Oncology Extra

Read More